FBTDX
Price
$103.76
Change
-$0.87 (-0.83%)
Updated
May 1 closing price
Net Assets
707.67M
PRHSX
Price
$77.42
Change
-$2.01 (-2.53%)
Updated
May 1 closing price
Net Assets
12.08B
Ad is loading...

FBTDX vs PRHSX

Header iconFBTDX vs PRHSX Comparison
Open Charts FBTDX vs PRHSXBanner chart's image
Franklin Biotechnology Discovery C
Price$103.76
Change-$0.87 (-0.83%)
VolumeN/A
Net Assets707.67M
T. Rowe Price Health Sciences
Price$77.42
Change-$2.01 (-2.53%)
VolumeN/A
Net Assets12.08B
FBTDX vs PRHSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTDX vs. PRHSX commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTDX is a Buy and PRHSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PRHSX has more cash in the bank: 12.1B vs. FBTDX (708M). PRHSX pays higher dividends than FBTDX: PRHSX (0.01) vs FBTDX (0.00). FBTDX was incepted earlier than PRHSX: FBTDX (11 years) vs PRHSX (29 years). FBTDX (1.81) is less costly to investors than PRHSX (0.80). PRHSX is a more actively managed with annual turnover of: 52.40 vs. FBTDX (35.87). FBTDX has a lower initial minimum investment than PRHSX: FBTDX (1000) vs PRHSX (2500). PRHSX annual gain was more profitable for investors over the last year : -12.66 vs. FBTDX (-15.38). PRHSX return over 5 years is better than : 0.83 vs. FBTDX (-24.78).
FBTDXPRHSXFBTDX / PRHSX
Total Expense Ratio1.800.80225%
Annual Report Gross Expense Ratio1.810.80226%
Fund Existence11 years29 years-
Gain YTD-3.709-0.1262,950%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets708M12.1B6%
Annual Yield % from dividends0.000.01-
Returns for 1 year-15.38-12.66122%
Returns for 3 years9.30-8.83-105%
Returns for 5 years-24.780.83-2,973%
Returns for 10 years-43.613.15-1,387%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBOX53.99N/A
N/A
Rydex Biotechnology A
NECOX20.94N/A
N/A
Natixis Oakmark C
VWNFX43.00N/A
N/A
Vanguard Windsor™ II Inv
LRSRX11.94N/A
N/A
Lord Abbett Small Cap Value R3
MGTSX36.50N/A
N/A
Morgan Stanley Inst Global Opp R6